Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia

Chinese Medical Journal

Volumn 112, Issue 12, 1999, Pages 1112-1118

  Xu, Kailin ^a   Wang, Li ^a   Hao, Yushu ^a   Shao, Zonghong ^a   Meng, Qingxiang ^a   Li, Ke ^a   Chao, Hengjun ^a   Tang, Kejing ^a   Wang, Ling ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Evi 1 MDS1 Evi 1; Gene expression; Myelodysplastic syndromes; Post MDS acute myeloid leukemia

Indexed keywords

CHIMERIC PROTEIN; DNA BINDING PROTEIN; DNA BINDING PROTEINS; EVI 1 PROTEIN; EVI-1 PROTEIN; MDS1 EVI1 FUSION PROTEIN; MDS1 PROTEIN; MDS1-EVI1 FUSION PROTEIN; PROTEIN; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; FEMALE; GENETICS; HUMAN; MALE; MYELODYSPLASTIC SYNDROME;

ADULT; AGED; CHIMERIC PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGE; MYELODYSPLASTIC SYNDROMES; PROTEINS; ZINC FINGERS;

EID: 0033302205     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nucifora G, Begy CR, Kobayashi H, et al. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3; 21) (q26; q22) translocations. Proc Natl Acad Sci U S A 1994; 91: 4004-4008.
2. Perkins AS, Fishel R, Jenkins NA, et al. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol Cell Biol 1991; 11: 2665-2674.
3. Levy ER, Parganas F, Morishita K, et al. DNA rearrangements proximal to the EVI1 locu associated with the 3q21q26 syndrome. Blood 1994; 83: 1348-1354.
4. Suzukawa K, Parganas E, Gajjar A, et al. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the Evi-1 gene in acute myelogenous leukemias with inv (3) (q21q26). Blood 1994; 84: 2681-2688.
5. Morishita K, Parganas E, William CL, et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc. Natl Acad Sci U S A 1992; 89: 3937-3941.
6. Fichelson S, Dreyfus F, Berger R, et al. Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 Chromosomal region Leukemia 1992; 6: 93-99.
7. Russell M, List A, Greenberg P, et al. Expression of Evi-1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 1994; 84: 1243-1248.
8. Dreyfus F, Bouscary D, Melle J, et al. Expression of the Evi-1 gene in myelodysplastic syndromes. Leukemia 1995; 9: 203-205.
9. Zent CS, Mathieu CM, Claxton DF, et al. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. Proc Natl Acad Sci U S A 1996; 93: 1044-1048.
10. Fears S, Mathieu C, ZeleznikLe N, et al. Intergene splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc Natl Acad Sci U S A 1996; 93: 1642-1647.
11. Soderholm J, Kobayashi H, Mathieu C, et al. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Leukemia 1997; 11: 352-358.
12. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
13. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
14. The Fourth Chinese Aplastic Anemia Symposium. Proposed revised criteria for the diagnosis of aplastic anemia. Chin J Hematol 1987; 8: 463-464.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120-5127.
17. Matsugi T, Morishita K, Ihle J. Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene. Mol Cell Biol 1990; 10: 1259-1264.
18. Perkins AS, Mercer JA, Jenkins NA, et al. Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important tole in mouse development. Development 1991; 111: 479-487.
19. Lopingco MC, Perkins AS. Molecular analysis of Evi-1, a zinc finger oncogene involved in myeloid leukemia. Curr Top Microbiol Immunol 1996; 211: 211-222.
20. Morishita K, Parganas E, Matsugi T, et al. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol 1992; 12: 183-189.
21. Kreider B, Orkin S, Ihle J. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid transforming gene. Proc Natl Acad Sci U S A 1993; 90: 6454-6458.
22. Willemze R, Fibbe WE, Falkenburg JHF, et al. Biology and treatment of myelodysplastic syndromes-developments in the past decade. Ann Hematol 1993; 66: 107-115.
23. Shao ZH, Hao YS. The progress in biology of Myelodysplastic syndromes. Chin J Hematol 1996; 17: 106-108.
24. Kuriyama K, Tomonaga M, Matsuo T, et al. Poor response to intensive chemotherapy in de novo acute myeloid leukemia with trilineage myelodysplasia. Br J Haematol 1994; 86: 767-773.
25. List A, Garewal H, Sandberg A. The myelodysplastic syndromes: Biology and implications for management. J Clin Oncol 1990; 8: 1424-1431.
26. Ohyashiki K, Ohyashiki JH, Fujieda H, et al. Evi-1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia. Leukemia 1996; 8: 2169-2173.
27. Ogawa S, Kurokawa M, Tanaka T, et al. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia 1996; 10: 788-794.
28. Nucifora G, Rowley JD. AML1 and the 8; 21 and 3; 21 translocations in acute and chronic myeloid leukemia. Blood 1995; 86: 1-14.
29. Mitani K, Ogawa S, Tanaka T, et al. Generation of the AML1-EVI-1 fusion gene in the t(3; 21) (q26; q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 1994; 13: 504-510.